-+ 0.00%
-+ 0.00%
-+ 0.00%

Odyssey Therapeutics Q1 EPS $(6.77) Misses $(1.13) Estimate

Benzinga·06/17/2026 20:53:23
Listen to the news
Odyssey Therapeutics (NASDAQ:ODTX) reported quarterly losses of $(6.77) per share which missed the analyst consensus estimate of $(1.13) by 499.12 percent. This is a 82.8 percent increase over losses of $(39.37) per share from the same period last year.